Thursday, December 24, 2020

Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine

Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. 

from Moneycontrol Business News https://ift.tt/3mPX0Vk

No comments:

Post a Comment

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...